Characterization of recombinant Modified Vaccinia virus Ankara delivering Zika virus nonstructural proteins NS2B and NS3pro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2021
- Schlagwort
-
Impfstoff
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Sutter, Gerd
- DOI
-
10.5282/edoc.28590
- URN
-
urn:nbn:de:bvb:19-285903
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwarz, Jan Hendrik
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Antigene des Vaccinia Virus
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system
Antigene des Vaccinia Virus
Characterization of recombinant Modified Vaccinia virus Ankara delivering African swine fever virus proteins
Characterization of recombinant Modified Vaccinia virus Ankara delivering immunomodulatory African swine fever virus proteins
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions
Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein
Characterization of fetal protection by vaccination with recombinant Modified Vaccinia virus Ankara in a Zika virus mouse model
Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus
Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein
Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system